CaineEDPolinskyRJ. Haloperidol induced dysphoria in patientes with Tourette's Syndrome. Am J Psychiatry1979;136:1216–7.
2.
CantwellDPSwansonJConnorDF. Case study: Adverse response to clonidine, J Am Acad Child Adolesc Psychiatry1997;36(4):539–44.
3.
CaineEDPolinskyRJKartzinelREbertM.The trial use of clozapine for abnormal involuntary movement disorders. Am J Psychiatry1979;136(3):317–20.
4.
LombrosoPJScahillLKingRALynchKAChappellPBPetersonBS, and others. Risperidone treatment of children and adolescents with chronic tic disorders: A preliminary report. J Am Acad Child Adolesc Psychiatry1995;34 (9):1147–52.
5.
StamenkovicMSchindlerSDAschauerHNKasperS.Olanzapine in Gilles de la Tourette syndrome patients. Eur Neuropsychopharmacol1998:8 (suppl 2):301S.
6.
SalleeFRKurlanRGoetzCGSingerHScahillLLawG, and others. Ziprasidone treatment of children and adolescents with Tourette's Syndrome: A pilot study. J Am Acad Child Adolesc Psychiatry2000;39(3):292–9.
7.
RichelsonE.Receptor pharmacology of neuroleptics: Relation to clinical effects. J Clin Psychiatry1999;60 (suppl 10):5–14.
8.
MeltzerHY. Preclinical pharmacology of atypical antipsychotic drugs. Neuropsychopharmacology1994;10(3S):368S.
9.
TauscherJKufferleBBarnasCAsenbaumSBrueckeTKasperS.Premedication influenced D2 receptor occupancy with quetiapine and sertindole. Biol Psychiatry1997;41(7S):13S;Abs 40.